<DOC>
	<DOC>NCT01122563</DOC>
	<brief_summary>This study is to evaluate change of overactive bladder symptom scores (OABSS) between, before and after solifenacin treatment to OAB subjects.</brief_summary>
	<brief_title>A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<criteria>Symptoms OAB for 3 months or longer At least 3 urgency episode in last 3 days Symptoms of OAB as verified by the screening 3day bladder diary, defined by: Number of micturition ≥8 times/day Number of urgency episodes in 3 days ≥3 Significant stress incontinence or mixed stress/urge incontinence Subject with indwelling catheters or practicing intermittent selfcatheterization Symptomatic urinary tract infection, chronic inflammation Diabetic neuropathy Subjects who are prohibited from taking solifenacin as contraindications Drug or nondrug treatment for OAB was started, quitted or changed in 4 weeks Participation in any clinical trial in 30 days except for Part1 of RESORT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>OABSS</keyword>
	<keyword>IPSS</keyword>
	<keyword>PPBC</keyword>
	<keyword>3-day micturition diary</keyword>
	<keyword>Solifenacin</keyword>
</DOC>